This inventor holds 2 USPTO granted patents. Top assignee: Institut Pasteur. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Stephanie Reynard
Introduction
Stephanie Reynard is a prominent inventor based in La Mulatiere, France. She has made significant contributions to the field of immunology through her innovative research and patents. With a total of 2 patents, her work focuses on the development of recombinant attenuated Mopeia virus (MOPV) for inducing immune responses.
Latest Patents
Reynard's latest patents include an immunogenic composition comprising a recombinant attenuated Mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity. This patent describes a recombinant attenuated Mopeia virus that includes a genomic S segment encoding a nucleoprotein with attenuated exonuclease activity, which may also encode a non-MOPV arenavirus glycoprotein. The use of this recombinant attenuated MOPV aims to induce an immune response in a subject. Another patent focuses on a similar recombinant attenuated Mopeia virus, emphasizing the modified nucleoprotein with reduced exonuclease activity and its potential applications in immune response induction.
Career Highlights
Stephanie Reynard is affiliated with the prestigious Institut Pasteur, where she conducts her research. Her work has garnered attention for its potential impact on vaccine development and immunotherapy.
Collaborations
Reynard collaborates with notable colleagues, including Sylvain Baize and Audrey Page, who contribute to her research endeavors.
Conclusion
Stephanie Reynard's innovative work in the field of immunology, particularly with recombinant attenuated Mopeia virus, showcases her dedication to advancing medical science. Her contributions are poised to make a significant impact on future vaccine development and immune response strategies.